Title |
The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers
|
---|---|
Published in |
BMC Neuroscience, September 2009
|
DOI | 10.1186/1471-2202-10-125 |
Pubmed ID | |
Authors |
Manuel Fernández Martínez, Xabier Elcoroaristizabal Martín, Luís Galdos Alcelay, Jessica Castro Flores, Juan María Uterga Valiente, Begoña Indakoetxea Juanbeltz, María Ángeles Gómez Beldarraín, Josefa Moraza López, María Carmen Gonzalez-Fernández, Ana Molano Salazar, Rocio Bereincua Gandarias, Sandra Inglés Borda, Nuria Ortiz Marqués, Miryam Barandiarán Amillano, María Carrasco Zabaleta, Marian M de Pancorbo |
Abstract |
The aim of this study is to examine the influence of the catechol-O-methyltranferase (COMT) gene (polymorphism Val158 Met) as a risk factor for Alzheimer's disease (AD) and mild cognitive impairment of amnesic type (MCI), and its synergistic effect with the apolipoprotein E gene (APOE).A total of 223 MCI patients, 345 AD and 253 healthy controls were analyzed. Clinical criteria and neuropsychological tests were used to establish diagnostic groups.The DNA Bank of the University of the Basque Country (UPV-EHU) (Spain) determined COMT Val158 Met and APOE genotypes using real time polymerase chain reaction (rtPCR) and polymerase chain reaction (PCR), and restriction fragment length polymorphism (RFLPs), respectively. Multinomial logistic regression models were used to determine the risk of AD and MCI. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 1% |
Unknown | 83 | 99% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 15 | 18% |
Student > Ph. D. Student | 11 | 13% |
Student > Master | 10 | 12% |
Student > Doctoral Student | 9 | 11% |
Other | 8 | 10% |
Other | 15 | 18% |
Unknown | 16 | 19% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 17 | 20% |
Psychology | 12 | 14% |
Agricultural and Biological Sciences | 11 | 13% |
Biochemistry, Genetics and Molecular Biology | 8 | 10% |
Neuroscience | 7 | 8% |
Other | 9 | 11% |
Unknown | 20 | 24% |